Visit our main locations
Canada Denmark
France Hungary
 Events
SOT 2011, Washington, DC
More Info 

Seminar: A Battery of Toxicity Screening Assays for Selection of Dermal Drug Candidates
More Info 

Fact Sheet 

 

Q2 2010 Highlights

    • Revenue of $15.2 million
    • Net loss of $1.8 million
    • Net loss per share of $0.03
    • Backlog of $25.7 million   

 

Investor Information

  • TSX Symbol: LRI
  • Shares Outstanding: 52.7M
  • Fully Diluted: 58.2M
  • Market Cap. June 1, 2010: approx. $16.0 M.
  • Year-end: December 31st

Ownership

  • Management: 3%
  • Institutions: ≈ 70%
  • Retail: ≈ 27%

 

Management Team

  • Luc Mainville, President and CEO
  • Alain Tanguay, CFO
  • Andy Makin, Managing Director, Denmark
  • Christopher Banks, Managing Director, Hungary

2009 Highlights

  • $53.3 million revenue
  • $10.4 million net loss
  • $0.39 loss per share
1-888-353-2240    
Resource center   
Inquiry form   
Client center   
     
Français | Home | About | Careers | Corporate Profile | Products | Animal Welfare | Events | Customers Services
Copyright © 2006 LAB Research Inc. All Rights Reserved | Data Privacy Policy